PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail offers hope for Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThis study tests a combination of two drugs (liposomal irinotecan and enlonstobart) in 30 women with ovarian cancer that has stopped responding to platinum-based chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. Participants will receive th…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 06:12 UTC
-
New hope for hard-to-treat ovarian cancer: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new drug called BL-M07D1 against standard chemotherapy in people with HER2-positive ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum-based treatment. About 404 adults aged 18-75 will be randomly assigned to receive either BL…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:10 UTC
-
New antibody cocktail aims to boost ovarian cancer surgery success
Disease control Not yet recruitingThis study tests whether adding a new antibody (Aitua) to standard chemotherapy before surgery can help remove more cancer in people with advanced high-grade serous ovarian cancer. About 82 newly diagnosed patients whose tumors are hard to fully remove will be randomly assigned t…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
New Triple-Drug cocktail targets recurrent ovarian cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (Benmelstobart, Anlotinib, and Cyclophosphamide) in 40 adults with recurrent ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if this mix can control the cancer longer and improve survival. Participants must h…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC